| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.07 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.081 | 0.07 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.07 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.07 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |